Jordan ML et al. |
Tacrolimus for rescue of refractory renal allograft rejection. |
1998 |
Transplant. Proc. |
pmid:9636511
|
Zeevi A et al. |
Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA. |
1990 |
Transplant. Proc. |
pmid:1689884
|
Morris RE et al. |
Comparative immunopharmacologic effects of FK 506 and CyA in in vivo models of organ transplantation. |
1990 |
Transplant. Proc. |
pmid:1689885
|
|
Reduced incidence of acute, refractory acute, and chronic rejection after liver transplantation with FK506-based immunosuppression. European FK506 Multicentre Liver Study Group. |
1994 |
Transplant. Proc. |
pmid:7527960
|
Neuhaus PJ |
Optimised first-line FK506-based protocols in liver transplantation: experience from the University Hospital Rudolf Virchow, Berlin. |
1994 |
Transplant. Proc. |
pmid:7527961
|
Klintmalm GB et al. |
Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group. |
1993 |
Transplant. Proc. |
pmid:7679826
|
Fukuzawa M and Okada A |
Analysis of mouse xenogeneic T-cell responses and the effect of FK 506 on these responses and on xeno-skin graft rejection. |
1994 |
Transplant. Proc. |
pmid:7513483
|
Wang XH et al. |
Tacrolimus vs CyA Neoral in combination with MMF and steroids after cadaveric renal transplantation. |
2000 |
Transplant. Proc. |
pmid:11119899
|
Jordan ML et al. |
FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7679827
|
Warty VS et al. |
Practical aspects of FK 506 analysis (Pittsburgh experience). |
1991 |
Transplant. Proc. |
pmid:1721259
|
Jusko WJ and D'Ambrosio R |
Monitoring FK 506 concentrations in plasma and whole blood. |
1991 |
Transplant. Proc. |
pmid:1721260
|
Sher LS et al. |
Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623212
|
Millis JM et al. |
Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. |
1996 |
Transplant. Proc. |
pmid:8623213
|
Yamamoto S et al. |
FK778 controls acute rejection after rat liver allotransplantation showing positive interaction with FK506. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808570
|
Aravot D et al. |
A new immunosuppressive protocol for lung transplantation: early promising results. |
2003 |
Transplant. Proc. |
pmid:12644072
|
Mollevà DG et al. |
Late xenograft rejection: comparison between liver and heart xenografts under low-dose tacrolimus. |
2002 |
Transplant. Proc. |
pmid:11959212
|
Cai TH et al. |
Improved immunosuppression with combination tacrolimus (FK506) and mycophenolic acid in orthotopic liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636572
|
Bond MMK et al. |
Cyclosporine Versus Tacrolimus: Which Calcineurin Inhibitor Has Influence on Cytomegalovirus Infection in Cardiac Transplantation? |
2018 |
Transplant. Proc. |
pmid:29661443
|
Lo CM et al. |
More effective immunosuppression with the use of FK506 after liver transplantation. |
2000 |
Transplant. Proc. |
pmid:11120161
|
Moriuchi H et al. |
Mechanisms of immunosuppressive effects of FK 506 in light of apoptosis of hepatocytes and infiltrating lymphocytes in rat allografted livers. |
2000 |
Transplant. Proc. |
pmid:11120182
|
Santos L et al. |
New-onset diabetes after transplantation: drug-related risk factors. |
2012 |
Transplant. Proc. |
pmid:23146462
|
van Hooff JP et al. |
Dosing and management guidelines for tacrolimus in renal transplant patients. |
1999 |
Transplant. Proc. |
pmid:10576046
|
McLachlan G et al. |
Growth inhibition of the MOLT-4 human T-leukemia cell line. A comparison of cyclosporine and FK 506. |
1991 |
Transplant. Proc. |
pmid:1721291
|
Oliveira DB and Chang R |
Report of the first 118 tacrolimus-treated patients at St George's Hospital, London. |
1999 |
Transplant. Proc. |
pmid:10576047
|
Asano T et al. |
Increased tacrolimus trough levels in association with severe diarrhea, a case report. |
2004 |
Transplant. Proc. |
pmid:15518758
|
D'Silva M et al. |
Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506. |
1996 |
Transplant. Proc. |
pmid:8623476
|
Ichimaru N et al. |
Risk factors and incidence for lipid abnormalities in kidney transplant patients. |
2015 |
Transplant. Proc. |
pmid:25891708
|
Merli M et al. |
Conversion from twice-daily to once-daily tacrolimus administration in liver transplant patient. |
2010 |
Transplant. Proc. |
pmid:20534292
|
Goulet O et al. |
Small bowel transplantation alone or with the liver in children: changes by using FK506. |
1998 |
Transplant. Proc. |
pmid:9636636
|
Gerber DA et al. |
Immunosuppressive agents: recent developments in molecular action and clinical application. |
1998 |
Transplant. Proc. |
pmid:9636637
|
Fan Y et al. |
Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis. |
2009 |
Transplant. Proc. |
pmid:19545736
|
Masri M et al. |
Prograf five milligrams versus Tacrolimus medis in healthy volunteers: a bioequivalence study. |
2013 |
Transplant. Proc. |
pmid:24314930
|
Xu M et al. |
Effect of peritransplant FTY720 alone or in combination with posttransplant FK 506 in a rat model of cardiac allotransplantation. |
1997 |
Transplant. Proc. |
pmid:9365631
|
Jacob DA et al. |
Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival. |
2005 |
Transplant. Proc. |
pmid:15919432
|
Spada M et al. |
Monitoring of intestinal myoelectrical activity after isolated small bowel transplantation in FK 506 immunosuppressed pigs. |
1994 |
Transplant. Proc. |
pmid:7518141
|
Ziolkowski J et al. |
Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity. |
2003 |
Transplant. Proc. |
pmid:14529923
|
Junge G et al. |
Withdrawal of steroids: a randomized prospective study of prednisone and tacrolimus versus mycophenolate mofetil and tacrolimus in liver transplant recipients with autoimmune hepatitis. |
2005 |
Transplant. Proc. |
pmid:15919434
|
Takai K et al. |
Delayed graft function after renal transplantation from a non-heart-beating donors. |
2003 |
Transplant. Proc. |
pmid:12591320
|
Yasunami Y et al. |
Induction of donor-specific unresponsiveness in rat islet allografts by FK 506. |
1992 |
Transplant. Proc. |
pmid:1376510
|
Martinez OM et al. |
Molecular markers of Epstein-Barr virus infection in the circulation of transplant recipients. |
1995 |
Transplant. Proc. |
pmid:7533372
|
Ciancio G et al. |
Pilot Randomized Trial of Tacrolimus/Everolimus vs Tacrolimus/Enteric-Coated Mycophenolate Sodium in Adult, Primary Kidney Transplant Recipients at a Single Center. |
|
Transplant. Proc. |
pmid:27569936
|
Wilusz M et al. |
Effect of immunosuppressive therapy on the serum fatty acids of phospholipids fraction in patients after heart transplantation. |
2014 |
Transplant. Proc. |
pmid:25380928
|
Motta I et al. |
FK 506 favors the generation of memory T cells in vitro. |
1991 |
Transplant. Proc. |
pmid:1721324
|
Isai H et al. |
FK 506 and orthotopic liver transplantation in the rat. |
1990 |
Transplant. Proc. |
pmid:1699329
|
Tannuri AC et al. |
Effects of immunosuppressants on hepatocyte cell mitosis during liver regeneration in growing animal models of partial hepatectomy. |
2008 |
Transplant. Proc. |
pmid:18589165
|
Loh PT et al. |
Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients. |
2008 |
Transplant. Proc. |
pmid:18589174
|
Mayer AD |
Chronic rejection and graft half-life: five-year follow-up of the European Tacrolimus Multicenter Renal Study. |
2002 |
Transplant. Proc. |
pmid:12176452
|
Esposito C et al. |
Effect of calcineurin inhibitors on extracellular matrix turnover in isolated human glomeruli. |
2004 |
Transplant. Proc. |
pmid:15110634
|
Orlandi V et al. |
Tacrolimus-associated myositis: a case report in a renal transplant patient. |
2004 |
Transplant. Proc. |
pmid:15110639
|
Pohanka E et al. |
Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients. |
2005 |
Transplant. Proc. |
pmid:15919490
|
Laskow DA et al. |
Phase II FK 506 multicenter concentration control study: one-year follow-up. |
1995 |
Transplant. Proc. |
pmid:7533431
|
Shapiro R et al. |
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533432
|
Reyes J et al. |
Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721355
|
Whiteside TL et al. |
Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506. |
1991 |
Transplant. Proc. |
pmid:1721356
|
Fischereder M et al. |
Gynaecomastia following solid organ transplantation. |
2002 |
Transplant. Proc. |
pmid:12270376
|
Budde K et al. |
Five year outcome of tacrolimus rescue therapy in late rejection after renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176499
|
Iaria G et al. |
Switch to tacrolimus for cyclosporine-induced gynecomastia in liver transplant recipients. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182769
|
Kociszewska-Najman B et al. |
Congenital Infections in Neonates of Women With Liver or Kidney Transplants. |
2016 |
Transplant. Proc. |
pmid:27496446
|
Shu KH et al. |
A multicenter trial of FK506 as rescue therapy for renal transplant recipients in Taiwan. |
1998 |
Transplant. Proc. |
pmid:9838570
|
Bennett WM |
Renal complications after heart transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083019
|
Ko S et al. |
Predominant role of local immunosuppressive effect in enhanced efficacy of liposomal FK506 in organ transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123117
|
Rao AS et al. |
Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. |
1996 |
Transplant. Proc. |
pmid:8908140
|
Kim YI et al. |
FK 506 prevents critical warm ischemia damage to the pig liver and improves hepatic microcirculation. |
1994 |
Transplant. Proc. |
pmid:7520636
|
Thomson AW et al. |
Immunosuppressive activity, T-cell subset analysis, and acute toxicity of FK-506 in rats. |
1989 |
Transplant. Proc. |
pmid:2468203
|
Hossein-Nia M et al. |
Urinary proteins as a marker of drug-induced renal damage following treatment with cyclosporine or FK 506. |
1991 |
Transplant. Proc. |
pmid:1721388
|
Baran DA et al. |
Tacrolimus and new onset diabetes mellitus: the effect of steroid weaning. |
2002 |
Transplant. Proc. |
pmid:12176547
|
Paul LC |
Overview of side effects of immunosuppressive therapy. |
2001 |
Transplant. Proc. |
pmid:11377462
|
Rodrigo E et al. |
Histopathological findings according to Banff-97 classification system comparing tacrolimus versus cyclosporine. |
2002 |
Transplant. Proc. |
pmid:12176550
|
Jordán de Luna C et al. |
Pharmacogenetic study of ABCB1 and CYP3A5 genes during the first year following heart transplantation regarding tacrolimus or cyclosporine levels. |
2011 Jul-Aug |
Transplant. Proc. |
pmid:21839244
|
Shapiro R et al. |
A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083507
|
Elinav H et al. |
Plasma oxidizability and plasma carbonyls, markers of oxidative stress, in liver transplant patients. |
2001 |
Transplant. Proc. |
pmid:11543789
|
Opelz G |
Immunosuppression with FK 506 does not improve kidney graft survival. Collaborative Transplant Study. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083513
|
Batten P et al. |
Effect of cyclosporine A and FK 506 on human T cell responses to xenogeneic and allogeneic endothelium: relative resistance of T cell/porcine endothelial interactions. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123582
|
Troppmann C et al. |
FK 506 versus cyclosporine A for steroid-free synergistic combination therapy with rapamycin in a discordant large animal donor xenoislet transplant model. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123585
|
Braun N et al. |
Impairment of renal function following liver transplantation. |
2003 |
Transplant. Proc. |
pmid:12826191
|
Yuzawa K et al. |
Topical immunosuppression in skin grafting with FK 506 ointment. |
1996 |
Transplant. Proc. |
pmid:8658707
|
Cooper MH et al. |
The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. |
1991 |
Transplant. Proc. |
pmid:1721419
|
Yagura K et al. |
Pharmacokinetic characteristics of two types of liposomal FK 506. |
1996 |
Transplant. Proc. |
pmid:8658708
|
Taber DJ et al. |
Drug-drug interaction between chloramphenicol and tacrolimus in a liver transplant recipient. |
2000 |
Transplant. Proc. |
pmid:10812156
|
Beckebaum S et al. |
Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective study. |
2004 |
Transplant. Proc. |
pmid:15621120
|
El-Sabrout R et al. |
Sirolimus in combination with tacrolimus or mycophenolate mofetil for minimizing acute rejection risk in renal transplant recipients--a single center experience. |
2003 |
Transplant. Proc. |
pmid:12742474
|
Filler G et al. |
One-year glomerular filtration rate predicts graft survival in pediatric renal recipients: a randomized trial of tacrolimus vs cyclosporine microemulsion. |
2002 |
Transplant. Proc. |
pmid:12176634
|
Rintala JM et al. |
The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression. |
2006 |
Transplant. Proc. |
pmid:17175234
|
Sahara H et al. |
Thymectomy does not abrogate long-term acceptance of MHC class I-disparate lung allografts in miniature Swine. |
2006 |
Transplant. Proc. |
pmid:17175240
|
Ishikawa S et al. |
Management of Juvenile Idiopathic Arthritis in ABO-incompatible Kidney Transplantation: A Case Report. |
2018 |
Transplant. Proc. |
pmid:29661455
|
Glanemann M et al. |
Mycophenolate mofetil is superior in combination with tacrolimus compared to cyclosporine for immunosuppressive therapy after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267194
|
Atillasoy E et al. |
Cholesterol levels long-term after liver transplant. |
1998 |
Transplant. Proc. |
pmid:9723387
|
Quijano Y et al. |
Tolerance: a study in long-term surviving animals after small bowel transplantation. |
1998 |
Transplant. Proc. |
pmid:9745494
|
Ybarra J et al. |
Reflex sympathetic dystrophy syndrome in renal transplanted patients under immunosuppression with tacrolimus. |
2003 |
Transplant. Proc. |
pmid:14697943
|
Neff GW et al. |
Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency. |
2003 |
Transplant. Proc. |
pmid:14697970
|
Yumiba T et al. |
Immunosuppressive and diabetogenic effect of FK 506 on pancreatic islet xenotransplantation. |
1995 |
Transplant. Proc. |
pmid:7540780
|
Nikolaidis NL et al. |
Metabolic effects of FK 506 in patients with severe psoriasis: short-term follow-up of seven cases. |
1991 |
Transplant. Proc. |
pmid:1721450
|
Velioglu A et al. |
Association of BK Virus Titers With Lymphocyte Count in Renal Transplant Patients. |
2015 |
Transplant. Proc. |
pmid:26093733
|
Ochiai T et al. |
Studies on FK506 in experimental organ transplantation. |
1988 |
Transplant. Proc. |
pmid:2450414
|
Mehra MR et al. |
Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267442
|
Yura H et al. |
Development of a macromolecular prodrug of FK 506: II: In vitro study for FK 506-dextran conjugate. |
1998 |
Transplant. Proc. |
pmid:9636416
|
Lautenschlager I et al. |
Efficiency of FK 506 and CyA to prevent acute cellular rejection of pig liver allografts. |
1991 |
Transplant. Proc. |
pmid:1714650
|
Wu J et al. |
Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation. |
1991 |
Transplant. Proc. |
pmid:1703683
|
Boggi U et al. |
Use of basiliximab in conjunction with either Neora/MMF/steroids or Prograf/MMF/steroids in simultaneous pancreas-kidney transplantation. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750373
|
Copley JB et al. |
Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts. |
1998 |
Transplant. Proc. |
pmid:9636510
|